Bed Bath & Beyond Inc. stock price, BBBY

Bed Bath & Beyond Inc. stock chart:



Bed Bath & Beyond Inc. close price: 41.09

Stock price forecast:

DOWN TO -1.14%
Target: 40.62

Total forecasts: 89
Reached: 65 (73.03%)

Total Win: 125.56 (286.39%)

DaysForecastsReached%Reached points%InvestedUnreached%Total%
90906673.33%127.873.25%980.963.540.36%131.413.40%
3030620.00%9.800.74%980.963.540.36%13.341.08%
141516.67%0.470.08%573.120.480.08%0.950.15%
78112.50%0.470.14%286.80-0.83-0.29%-0.36-0.11%

Showing 1-10 of 424 items.
Date of ForecastStock PriceTarget PriceForecast Reached Date
2017-01-1941.0940.610000-00-00
2017-01-1841.1440.50000-00-00
2017-01-1740.9240.440000-00-00
2017-01-1640.9240.390000-00-00
2017-01-1540.9240.530000-00-00
2017-01-1440.9240.520000-00-00
2017-01-1340.8940.510000-00-00
2017-01-1240.641.072017-01-17
2017-01-1140.7541.480000-00-00
2017-01-1040.4442.190000-00-00

Bed Bath & Beyond Inc. latest news:


  • 12/22/2016 10:15:52

    Bed Bath & Beyond Sinks on Earnings


  • 12/21/2016 14:28:32

    Bed Bath & Beyond drops after disappointing earnings, forecast

    Bed Bath & Beyond Inc. shares fell more than 5% in late trading Wednesday after the retail chain announced earnings and a forecast that came in lower than expectations. The company said it had net income of $126.4 million, or 85 cents a share, on sales of $2.96 billion in its fiscal third quarter, reflecting a stark decline in profit from $1.09 a share in the same period a year before. Analysts polled by FactSet expected the company to report earnings of 98 cents a share on sales of $3 billion. Bed Bath & Beyond also said it now expects full fiscal-year profit to be at the low end of its guidance range, which was $4.50 a share to about $5 a share. Analysts had projected full-year earnings of $4.73 a share, according to FactSet. Bed Bath & Beyond stock fell to less than $43.50 in after-hours trading, after closing with a 1.4% decline at $45.56.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

  • More trends:

    Bel Fuse Inc.BELFA | Bel Fuse Inc.BELFB | Bellerophon Therapeutics, Inc.BLPH | Bellicum Pharmaceuticals, Inc.BLCM | Beneficial Bancorp, Inc.BNCL | Benefitfocus, Inc.BNFT | Benitec Biopharma LimitedBNTC | Benitec Biopharma LimitedBNTCW | BG Medicine, Inc.BGMD | BGC Partners, Inc.BGCP |